Morrison & Foerster’s intellectual property litigators are known for their excellent courtroom skills, their ability to analyze the key issues in a case and develop a novel solution for resolving or winning it, and their depth of experience in industries such as life sciences and information technology. Most recently, our IP litigation practice was recognized as the 2013 Chambers USA Intellectual Property Firm of the Year and a 2012 Law360 Practice Group of the Year.
Clients rely on our deep and talented pool of litigators, including a number of the most accomplished trial attorneys in the U.S. The size and experience of our patent litigation team has provided us with expertise in a variety of venues, including all of the district courts that handle high volumes of patent litigation, the U.S. International Trade Commission, and the U.S. Court of Appeals for the Federal Circuit. In fact, we were one of the most active in district court representations, ranking second among all law firms in a recent survey. Our experience resolving patent issues is one of the singular strengths of the firm.
Our team approach ensures that litigation clients whose cases include scientific or other complex issues benefit from the integration of our patent prosecution practice with our IP litigation practice. Our clients include both U.S. and non-U.S. concerns, including major corporations, new information technology and life sciences ventures, universities, and nonprofit research institutions. We bring substantial expertise in fields such as biotechnology, chemical technology, communications, electronics, medical devices, pharmaceuticals, and software. We are also one of a small number of U.S. law firms with a significant international IP litigation practice. Our offices in Asia, and particularly in Japan, regularly represent clients such as Fujitsui, Hitachi, and Toshiba in international patent litigation matters.
Our intellectual property litigators have won scores of high-stakes cases involving disputes over key patents, trademarks, and other intellectual property for clients such as Bayer, Chiron, EchoStar, Novartis, and Pioneer.